The same applies if you experience severe chest pain or severe breathlessness
This slow escalation helps improve tolerability, as the gastrointestinal side effects are often dose-related
Semaglutide offers a bit more flexibility: its available in both once-weekly and once-daily injection forms, giving you more options depending on your schedule and preferences
It followed up with Zepbound for weight loss, which was approved in 2023
Most patients notice meaningful shifts in appetite and food preoccupation within the first two to four weeks
This pharmacokinetic profile supports once-weekly subcutaneous administration, delivered via prefilled autoinjector pens available in 0.75 mg, 1.5 mg, 3.0 mg, and 4.5 mg per 0.5 mL dose strengths [54]